GlobalData’s clinical trial report, “Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Global Clinical Trials Review, H1, 2014” provides data on the Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) to Central Nervous System Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) to Central Nervous System Clinical Trials 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
CSL Limited 30
Clinical Trial Overview of CSL Limited 30
LFB S.A. 31
Clinical Trial Overview of LFB S.A. 31
Biogen Idec Inc. 32
Clinical Trial Overview of Biogen Idec Inc. 32
Takeda Pharmaceutical Company Limited 33
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 33
Octapharma AG 34
Clinical Trial Overview of Octapharma AG 34
Novartis AG 35
Clinical Trial Overview of Novartis AG 35
Kedrion S.p.A. 36
Clinical Trial Overview of Kedrion S.p.A. 36
Grifols, S.A. 37
Clinical Trial Overview of Grifols, S.A. 37
Grifols Deutschland Gmbh 38
Clinical Trial Overview of Grifols Deutschland Gmbh 38
GeNeuro SA 39
Clinical Trial Overview of GeNeuro SA 39
Clinical Trial Overview of Top Institutes / Government 40
National Center for Research Resources 40
Clinical Trial Overview of National Center for Research Resources 40
Aarhus University 41
Clinical Trial Overview of Aarhus University 41
Erasmus MC 42
Clinical Trial Overview of Erasmus MC 42
State University of New York at Buffalo 43
Clinical Trial Overview of State University of New York at Buffalo 43
Stony Brook University 44
Clinical Trial Overview of Stony Brook University 44
University of Cologne 45
Clinical Trial Overview of University of Cologne 45
Northwestern University 46
Clinical Trial Overview of Northwestern University 46
Centre Hospitalier Universitaire de Saint Etienne 47
Clinical Trial Overview of Centre Hospitalier Universitaire de Saint Etienne 47
Oregon Health and Science University 48
Clinical Trial Overview of Oregon Health and Science University 48
Rigshospitalet 49
Clinical Trial Overview of Rigshospitalet 49
Five Key Clinical Profiles 50
Appendix 92
Abbreviations 92
Definitions 92
Research Methodology 93
Secondary Research 93
About GlobalData 94
Contact Us 94
Disclaimer 94
Source 94

List of Tables

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, Global, Clinical Trials by Region, 2014* 8
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 9
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 10
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 11
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 12
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, North America, Top Countries, 2014* 13
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 14
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 15
Proportion of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 16
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 17
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 18
Proportion of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 19
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, Global, Withdrawn Clinical Trials, 2014* 24
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, Global, Terminated Clinical Trials, 2014* 24
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Limited, 2014* 30
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by LFB S.A., 2014* 31
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2014* 32
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014* 33
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Octapharma AG, 2014* 34
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 35
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kedrion S.p.A., 2014* 36
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Grifols, S.A., 2014* 37
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Grifols Deutschland Gmbh, 2014* 38
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by GeNeuro SA, 2014* 39
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014* 40
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2014* 41
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014* 42
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by State University of New York at Buffalo, 2014* 43
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Stony Brook University, 2014* 44
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cologne, 2014* 45
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014* 46
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Saint Etienne, 2014* 47
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2014* 48
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2014* 49

List of Figures

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, Global, Clinical Trials by Region (%), 2014* 8
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 9
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 10
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 11
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 12
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 13
Proportion of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 16
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 17
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 18
Proportion of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 19
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 93